Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
In brief, this research is a prospective, feasibility study to evaluate the use of Betashot- a medium chain triglyceride- based (MCT) food for special medical purposes (FSMP) in children and adults diagnosed with epilepsy.
MCT is a type of dietary fat used in the ketogenic diet.
Full description
This study aims to explore the use of Betashot in a group of children and adults with epilepsy who are consuming their normal diets, but limiting intakes of foods high in carbohydrate and sugars.
The participants will be required to drink Betashot to enable the following assessment:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Children aged 3-18 years with symptoms of epilepsy continuing despite adequate levels of anti-epileptic medication, either with a diagnosis of Dravet syndrome or another early onset epilepsy, the result of a genetic mutation.
Adults (aged over 18) with symptoms of epilepsy continuing despite adequate levels of anti-epileptic medication.
Participant/Parent/guardian to comply with the study protocol and participate in active monitoring of tolerance, acceptability and compliance of Betashot via a written record, and to complete questionnaires.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
77 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal